Mechanism of Action
12.1 Mechanism of Action NUZYRA is an antibacterial drug [see ]. 12.2 Pharmacodynamics Cardiac Electrophysiology Based on the nonclinical and clinical data, including electrocardiogram evaluation in the phase 3 clinical trials, one of which had moxifloxacin as a control group, no clinically…
Tetracycline-class Antibacterial
Indications (12)
Clinical Trials (5)
A Study to Compare the Effect of Omadacycline Versus Moxifloxacin in Healthy Adult Volunteers
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
Effects of Intravenous (IV) Omadacycline on Gut Microbiome
Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections